Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4917 total record number 289 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 188 out of 492
4917 citations found

Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation

Cho, JJ;Xu, Z;Parthasarathy, U;Drashansky, TT;Helm, EY;Zuniga, AN;Lorentsen, KJ;Mansouri, S;Cho, JY;Edelmann, MJ;Duong, DM;Gehring, T;Seeholzer, T;Krappmann, D;Uddin, MN;Califano, D;Wang, RL;Jin, L;Li, H;Lv, D;Zhou, D;Zhou, L;Avram, D;

Product: Pertussis Toxin from B. pertussis (in Glycerol)

  • Active EAE Induction

    MOG35–55 peptide with amino acid sequence MEVGWYRSPFSRVVHLYRNGK was purchased from Mimotopes (Mimotopes, Victoria, Australia) and resuspended in 0.09% saline solution at a concentration of 2 mg/ml. Fresh complete Freund’s adjuvant (CFA) was reconstituted with 4 mg/ml non-viable, desiccated Mycobacterium tuberculosis H37 Ra (Cat#231141, BD, MD, USA) in incomplete Freund’s adjuvant (Cat#F5506, Sigma, Millipore-Sigma, MO, USA). Pertussis toxin from Bordetella pertussis in glycerol (Cat#179B, List Biological Laboratories, CA, USA) was freshly diluted in PBS to 3 μg/ml. MOG35–55/CFA emulsion was freshly reconstituted by mixing equal volume of 2 mg/ml MOG35–55 with CFA and vortexed for 30 min at room temperature. For each mouse, a total of 200 μl MOG35–55/CFA emulsion was subcutaneously injected at flank and scruff sites; 100 μl of 3 μg/ml pertussis toxin was administered intraperitoneally 1 h and 24 h following MOG35–55/CFA emulsion. Clinical scoring was performed starting 7 days following active EAE induction, every day until the completion of the experiment. …

    Product #179A – Pertussis Toxin from B. pertussis (in Glycerol)

Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillusanthracis spore inhalation challenge

Weir, GM;MacDonald, LD;Rajagopalan, R;Sivko, GS;Valderas, MW;Rayner, J;Berger, BJ;Sammatur, L;Stanford, MM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Vaccine preparation and immunization:

    DPX-rPA and alum-rPA were provided by IMV Inc. (Halifax, Canada), but AVA was provided by the CDC. Test and vehicle/control article formulations were prepared fresh on the day of dosing in accordance with the method provided. DPX-rPA was prepared as previously described19 containing a poly I:C (Thermo Fisher) or Pam3CSK4 (EMC Microcollections) adjuvant and a 10:1 mixture of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine):cholesterol (Lipoid GmBH, Germany) or S100:cholesterol (Lipoid GmBH), see Supplementary Table 1 for complete formulation details for each figure. The source of rPA was DRDC, List Biologicals, or Pfenex Inc.26 …

Increased expression of endoplasmic reticulum stress-related caspase-12 and CHOP in the hippocampus of EAE mice

Kamarehei, M;Ardestani, SK;Firouzi, M;Zahednasab, H;Harirchian, MH;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Protection from EAE in DOCK8 mutant mice occurs despite increased Th17 cell frequencies in the periphery

Wilson, AS;Law, HD;Knobbe-Thomsen, CB;Kearney, CJ;Oliaro, J;Binsfeld, C;Burgio, G;Starrs, L;Brenner, D;Randall, KL;Brstle, A;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets

Mould, KJ;Jackson, ND;Henson, PM;Seibold, MA;Janssen, WJ;

Product: LPS from Escherichia coli O55:B5

  • Acute lung inflammation model:

    LPS (E. coli O55:B5 from List Biological Laboratories) (20 g) in 50 l of PBS was instilled directly into the tracheas of mice sedated with isofluorane (Baxter) using a modified feeding needle (59). Mice were sacrificed using i.p. injection of pentobarbital sodium solution.

A therapeutic human antibody against the domain 4 of the Bacillus anthracis protective antigen shows protective efficacy in a mouse model

Ahn, BE;Bae, HW;Lee, HR;Woo, SJ;Park, OK;Jeon, JH;Park, J;Rhie, GE;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Prophylactic Treatment with Intravenous Immunoglobulin Attenuates Experimental Optic Neuritis in Mice

Takahashi, H;Okuda, S;Tamura, M;Kamei, S;Aizawa, R;Kobayashi, T;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

IL-10 produced by macrophages regulates epithelial integrity in the small intestine

Morhardt, TL;Hayashi, A;Ochi, T;Quirs, M;Kitamoto, S;Nagao-Kitamoto, H;Kuffa, P;Atarashi, K;Honda, K;Kao, JY;Nusrat, A;Kamada, N;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages

de Vasconcelos, NM;Vliegen, G;Gonalves, A;De Hert, E;Martn-Prez, R;Van Opdenbosch, N;Jallapally, A;Geiss-Friedlander, R;Lambeir, AM;Augustyns, K;Van Der Veken, P;De Meester, I;Lamkanfi, M;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • Reagents:

    B. anthracis lethal factor (LF) was acquired from List Biologicals (#172C). …

    J774.A1 culture and stimulation:

    J774.A1 cells were cultured in IMDM (Lonza) containing 10% (vol/vol) heat-inactivated FBS, 1% (vol/vol) nonessential amino acids (Lonza), 100 U/ml penicillin, and 100 mg/ml streptomycin at 37C in a humidified atmosphere containing 5% CO2. Cells were scraped for passages and, for experiments, counted and seeded into 96-well plates in culturing medium. On the next day, cells were changed to fresh media and stimulated with vehicle or 1 g/ml PA combined with 0.5 g/ml LF (LeTx), VBP (0.1% TFA in DMSO) or 1G244 (DMSO) at a final concentration of 10 M or 25 M.

Botulinum neurotoxin serotype D – a potential treatment alternative for BoNT/A and B non-responding patients

Kutschenko, A;Weisemann, J;Kollewe, K;Fiedler, T;Alvermann, S;Bselt, S;Escher, C;Garde, N;Gingele, S;Kaehler, S;Karatschai, R;Krger, T;Sikorra, S;Tacik, P;Wegner, F;Wollmann, J;Bigalke, H;Wohlfarth, K;Rummel, A;

Product: Botulinum Neurotoxin Type A from Clostridium botulinum

  • … To compare the potency of BoNT/D with BoNT/A (subtype BoNT/A1; List Laboratories Inc.), the drug substance of incobotulinumtoxinA, concentration-response curves were constructed from three data points, each determined at least in triplicate, fitted to the logarithmic functions y(BoNT/D) = -25.548Ln(x) + 233.4, R2 = 1.0 and y(BoNT/A) = -37.817Ln(x) + 259.88, R2 = 0.9885. …